{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:33:07Z","timestamp":1790281987239,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03927-9","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:05:00Z","timestamp":1763463900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utilizing a novel mitochondrial-related gene signature for predicting the prognosis and immunological impact in bladder cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Gongping","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengwei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongnuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"3927_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3927_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/bju.14915","volume":"125","author":"J Taylor","year":"2020","unstructured":"Taylor J, Becher E, Steinberg GD. Update on the guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int. 2020;125:197\u2013205.","journal-title":"BJU Int"},{"key":"3927_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71:96\u2013108.","journal-title":"Eur Urol"},{"key":"3927_CR4","first-page":"2796","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, et al. Bladder Cancer Lancet. 2016;388:2796\u2013810.","journal-title":"Bladder Cancer Lancet"},{"key":"3927_CR5","first-page":"404","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70:404\u201323.","journal-title":"CA Cancer J Clin"},{"key":"3927_CR6","doi-asserted-by":"publisher","first-page":"13461","DOI":"10.2147\/IJN.S498729","volume":"19","author":"X Zhao","year":"2024","unstructured":"Zhao X, Qi X, Liu D, et al. A novel approach for bladder cancer treatment: nanoparticles as a drug delivery system. Int J Nanomed. 2024;19:13461\u201383.","journal-title":"Int J Nanomed"},{"key":"3927_CR7","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/s41467-021-22163-7","volume":"12","author":"X Shangguan","year":"2021","unstructured":"Shangguan X, He J, Ma Z, et al. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis. Nat Commun. 2021;12:1812.","journal-title":"Nat Commun"},{"key":"3927_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3927_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.7150\/ijbs.81609","volume":"19","author":"Y Liu","year":"2023","unstructured":"Liu Y, Sun Y, Guo Y, et al. An overview: the diversified role of mitochondria in cancer metabolism. Int J Biol Sci. 2023;19:897\u2013915.","journal-title":"Int J Biol Sci"},{"key":"3927_CR10","first-page":"555","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC. Mitochondria Cancer Cell. 2016;166:555\u201366.","journal-title":"Mitochondria Cancer Cell"},{"key":"3927_CR11","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nrc3365","volume":"12","author":"DC Wallace","year":"2012","unstructured":"Wallace DC. Mitochondria and cancer. Nat Rev Cancer. 2012;12:685\u201398.","journal-title":"Nat Rev Cancer"},{"key":"3927_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21:297\u2013308.","journal-title":"Cancer Cell"},{"key":"3927_CR13","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.3390\/ijms22063245","volume":"22","author":"LX Zampieri","year":"2021","unstructured":"Zampieri LX, Silva-Almeida C, Rondeau JD, et al. Mitochondrial transfer in cancer: a comprehensive review. Int J Mol Sci. 2021;22:3245.","journal-title":"Int J Mol Sci"},{"key":"3927_CR14","doi-asserted-by":"publisher","first-page":"1327717","DOI":"10.3389\/fphar.2023.1327717","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang T, Ma W, et al. Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy. Front Pharmacol. 2023;14:1327717.","journal-title":"Front Pharmacol"},{"key":"3927_CR15","first-page":"10","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang G, Xu P, et al. Optimized dynamic network biomarker Deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med Res. 2025;1:10\u201331.","journal-title":"Med Res"},{"key":"3927_CR16","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/cr.2009.69","volume":"19","author":"J Lu","year":"2009","unstructured":"Lu J, Sharma LK, Bai Y. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009;19:802\u201315.","journal-title":"Cell Res"},{"key":"3927_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ajmg.1398","volume":"106","author":"S Raha","year":"2001","unstructured":"Raha S, Robinson BH. Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet. 2001;106:62\u201370.","journal-title":"Am J Med Genet"},{"key":"3927_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","volume":"108","author":"RW Johnstone","year":"2002","unstructured":"Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002;108:153\u201364.","journal-title":"Cell"},{"key":"3927_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tcb.2014.11.006","volume":"25","author":"F Klemm","year":"2015","unstructured":"Klemm F, Joyce JA. Microenvironmental regulation of therapeutic response in cancer. Trends Cell Biol. 2015;25:198\u2013213.","journal-title":"Trends Cell Biol"},{"key":"3927_CR20","doi-asserted-by":"publisher","first-page":"e25961","DOI":"10.4161\/onci.25961","volume":"2","author":"C Devaud","year":"2013","unstructured":"Devaud C, John LB, Westwood JA, et al. Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy. Oncoimmunology. 2013;2:e25961.","journal-title":"Oncoimmunology"},{"key":"3927_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2015.10.009","volume":"370","author":"H Tang","year":"2016","unstructured":"Tang H, Qiao J, Fu YX. Immunotherapy and tumor microenvironment. Cancer Lett. 2016;370:85\u201390.","journal-title":"Cancer Lett"},{"key":"3927_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","volume":"166","author":"MD Buck","year":"2016","unstructured":"Buck MD, O\u2019Sullivan D, Klein Geltink RI, et al. Mitochondrial dynamics controls T cell fate through metabolic programming. Cell. 2016;166:63\u201376.","journal-title":"Cell"},{"key":"3927_CR23","doi-asserted-by":"publisher","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","volume":"49","author":"S Rath","year":"2021","unstructured":"Rath S, Sharma R, Gupta R, et al. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. Nucleic Acids Res. 2021;49:D1541\u20137.","journal-title":"Nucleic Acids Res"},{"key":"3927_CR24","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3927_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373.","journal-title":"Nat Genet"},{"key":"3927_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12894-023-01382-8","volume":"23","author":"S Zhu","year":"2023","unstructured":"Zhu S, Zhao Q, Fan Y, et al. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings. BMC Urol. 2023;23:199.","journal-title":"BMC Urol"},{"key":"3927_CR27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12672-024-01575-z","volume":"15","author":"Dming Song","year":"2024","unstructured":"Song Dming, Feng K, Luo W, fei, et al. Predicting survival in bladder cancer with a novel apoptotic gene-related prognostic model. Discov Oncol. 2024;15:702.","journal-title":"Discov Oncol"},{"key":"3927_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12859-023-05241-z","volume":"24","author":"C Li","year":"2023","unstructured":"Li C, Xie W. Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer. BMC Bioinf. 2023;24:118.","journal-title":"BMC Bioinf"},{"key":"3927_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s40001-024-01982-6","volume":"29","author":"F Zheng","year":"2024","unstructured":"Zheng F, Wang Z, Li S, et al. Development of a propionate metabolism-related gene-based molecular subtypes and scoring system for predicting prognosis in bladder cancer. Eur J Med Res. 2024;29:393.","journal-title":"Eur J Med Res"},{"key":"3927_CR30","doi-asserted-by":"publisher","first-page":"e25573","DOI":"10.1016\/j.heliyon.2024.e25573","volume":"10","author":"G Pan","year":"2024","unstructured":"Pan G, Xie H, Xia Y. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer. Heliyon. 2024;10:e25573.","journal-title":"Heliyon"},{"key":"3927_CR31","doi-asserted-by":"publisher","first-page":"1088931","DOI":"10.3389\/fonc.2022.1088931","volume":"12","author":"P Zhang","year":"2022","unstructured":"Zhang P, Pei S, Liu J, et al. Cuproptosis-related LncRNA signatures: predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma. Front Oncol. 2022;12:1088931.","journal-title":"Front Oncol"},{"key":"3927_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.gde.2016.02.007","volume":"38","author":"WM Kamp","year":"2016","unstructured":"Kamp WM, Wang PY, Hwang PM. TP53 mutation, mitochondria and cancer. Curr Opin Genet Dev. 2016;38:16\u201322.","journal-title":"Curr Opin Genet Dev"},{"key":"3927_CR33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbabio.2017.01.004","volume":"1858","author":"S Srinivasan","year":"2017","unstructured":"Srinivasan S, Guha M, Kashina A, et al. Mitochondrial dysfunction and mitochondrial dynamics-the cancer connection. Biochim Biophys Acta. 2017;1858:602\u201314.","journal-title":"Biochim Biophys Acta"},{"key":"3927_CR34","doi-asserted-by":"crossref","unstructured":"Zhang G, Frederick DT, Wu L, et al. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. J Clin Invest. 126:1834\u201356.","DOI":"10.1172\/JCI82661"},{"key":"3927_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41467-024-55768-9","volume":"16","author":"Y Yi","year":"2025","unstructured":"Yi Y, Wang G, Zhang W, et al. Mitochondrial-cytochrome c oxidase II promotes Glutaminolysis to sustain tumor cell survival upon glucose deprivation. Nat Commun. 2025;16:212.","journal-title":"Nat Commun"},{"key":"3927_CR36","first-page":"423","volume":"92","author":"D Eugenio-P\u00e9rez","year":"2019","unstructured":"Eugenio-P\u00e9rez D, Briones-Herrera A, Mart\u00ednez-Klimova E, et al. Divide et impera: Drp1-mediated mitochondrial fission in glioma malignancy. Yale J Biol Med. 2019;92:423\u201333.","journal-title":"Yale J Biol Med"},{"key":"3927_CR37","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/15548627.2016.1166318","volume":"12","author":"Q Huang","year":"2016","unstructured":"Huang Q, Zhan L, Cao H, et al. Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy. 2016;12:999\u20131014.","journal-title":"Autophagy"},{"key":"3927_CR38","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.2147\/CMAR.S296038","volume":"13","author":"M Cai","year":"2021","unstructured":"Cai M, Li H, Chen R, et al. MRPL13 promotes tumor cell proliferation, migration and EMT process in breast cancer through the PI3K-AKT-mTOR pathway. Cancer Manag Res. 2021;13:2009\u201324.","journal-title":"Cancer Manag Res"},{"key":"3927_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s40291-019-00410-4","volume":"23","author":"Q Li","year":"2019","unstructured":"Li Q, Wang H, Peng H, et al. MicroRNAs: key players in bladder cancer. Mol Diagn Ther. 2019;23:579\u2013601.","journal-title":"Mol Diagn Ther"},{"key":"3927_CR40","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.omtn.2023.07.009","volume":"33","author":"C Wei","year":"2023","unstructured":"Wei C, Xu Y, Shen Q, et al. Role of long non-coding RNAs in cancer: from subcellular localization to nanoparticle-mediated targeted regulation. Mol Ther Nucleic Acids. 2023;33:774\u201393.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3927_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccell.2024.01.007","volume":"42","author":"X Yang","year":"2024","unstructured":"Yang X, Yang C, Zhang S, et al. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell. 2024;42:180\u201397.","journal-title":"Cancer Cell"},{"key":"3927_CR42","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.cub.2004.04.046","volume":"14","author":"JA Del R\u0131\u0301o","year":"2004","unstructured":"Del R\u0131\u0301o JA, Gonz\u00e1lez-Billault C, Ure\u00f1a JM, et al. MAP1B is required for Netrin 1 signaling in neuronal migration and axonal GuidanceMAP1B. Curr Biol. 2004;14:840\u201350.","journal-title":"Curr Biol"},{"key":"3927_CR43","doi-asserted-by":"publisher","first-page":"e202303102","DOI":"10.1083\/jcb.202303102","volume":"223","author":"H Inoue","year":"2024","unstructured":"Inoue H, Kanda T, Hayashi G, et al. A MAP1B-cortactin-Tks5 axis regulates TNBC invasion and tumorigenesis. J Cell Biol. 2024;223:e202303102.","journal-title":"J Cell Biol"},{"key":"3927_CR44","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00726-021-03060-1","volume":"53","author":"P Geng","year":"2021","unstructured":"Geng P, Qin W, Xu G. Proline metabolism in cancer. Amino Acids. 2021;53:1769\u201377.","journal-title":"Amino Acids"},{"key":"3927_CR45","doi-asserted-by":"publisher","first-page":"e70045","DOI":"10.1002\/ctm2.70045","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang H, Xu M, Zhang T, et al. PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification. Clin Transl Med. 2024;14:e70045.","journal-title":"Clin Transl Med"},{"key":"3927_CR46","doi-asserted-by":"publisher","first-page":"eadj5705","DOI":"10.1126\/scitranslmed.adj5705","volume":"16","author":"G Fan","year":"2024","unstructured":"Fan G, Yu B, Tang L, et al. TSPAN8\u2009+\u2009myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer. Sci Transl Med. 2024;16:eadj5705.","journal-title":"Sci Transl Med"},{"key":"3927_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12032-016-0870-5","volume":"34","author":"T Zeng","year":"2017","unstructured":"Zeng T, Zhu L, Liao M, et al. Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer. Med Oncol (northwood Lond Engl). 2017;34:27.","journal-title":"Med Oncol (northwood Lond Engl)"},{"key":"3927_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10863-021-09887-3","volume":"53","author":"S Du","year":"2021","unstructured":"Du S, Sui Y, Ren W, et al. PYCR1 promotes bladder cancer by affecting the akt\/wnt\/\u03b2-catenin signaling. J Bioenerg Biomembr. 2021;53:247\u201358.","journal-title":"J Bioenerg Biomembr"},{"key":"3927_CR49","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nrc1474","volume":"4","author":"CA Borgo\u00f1o","year":"2004","unstructured":"Borgo\u00f1o CA, Diamandis EP. The emerging roles of human tissue Kallikreins in cancer. Nat Rev Cancer. 2004;4:876\u201390.","journal-title":"Nat Rev Cancer"},{"key":"3927_CR50","doi-asserted-by":"publisher","first-page":"8198","DOI":"10.1158\/0008-5472.CAN-07-0607","volume":"67","author":"B Klucky","year":"2007","unstructured":"Klucky B, Mueller R, Vogt I, et al. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res. 2007;67:8198\u2013206.","journal-title":"Cancer Res"},{"key":"3927_CR51","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.cell.2013.07.029","volume":"154","author":"KH Chang","year":"2013","unstructured":"Chang KH, Li R, Kuri B, et al. A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer. Cell. 2013;154:1074\u201384.","journal-title":"Cell"},{"key":"3927_CR52","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/jamaoncol.2017.3158","volume":"4","author":"AW Hahn","year":"2018","unstructured":"Hahn AW, Pal SK, Agarwal N. HSD3B1\u2014a predictive biomarker in advanced prostate cancer. JAMA Oncol. 2018;4:562\u20133.","journal-title":"JAMA Oncol"},{"key":"3927_CR53","unstructured":"Tyrosine metabolism: identification of a key residue in the acquisition of prephenate aminotransferase activity by 1\u03b2 aspartate aminotransferase."},{"key":"3927_CR54","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s13238-010-0128-5","volume":"1","author":"P Mehere","year":"2010","unstructured":"Mehere P, Han Q, Lemkul JA, et al. Tyrosine aminotransferase: biochemical and structural properties and molecular dynamics simulations. Protein Cell. 2010;1:1023\u201332.","journal-title":"Protein Cell"},{"key":"3927_CR55","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/biom14091088","volume":"14","author":"F Xie","year":"2024","unstructured":"Xie F, Hua S, Guo Y, et al. Identification of TAT as a biomarker involved in cell cycle and DNA repair in breast cancer. Biomolecules. 2024;14:1088.","journal-title":"Biomolecules"},{"key":"3927_CR56","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.3390\/cancers13184712","volume":"13","author":"MM Leblond","year":"2021","unstructured":"Leblond MM, Zdimerova H, Desponds E, et al. Tumor-associated macrophages in bladder cancer: biological role, impact on therapeutic response and perspectives for immunotherapy. Cancers (Basel). 2021;13:4712.","journal-title":"Cancers (Basel)"},{"key":"3927_CR57","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization States in the tumor microenvironment. Int J Mol Sci. 2021;22:6995.","journal-title":"Int J Mol Sci"},{"key":"3927_CR58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.addr.2015.11.009","volume":"99","author":"Y Komohara","year":"2016","unstructured":"Komohara Y, Fujiwara Y, Ohnishi K, et al. Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy. Adv Drug Delivery Rev. 2016;99:180\u20135.","journal-title":"Adv Drug Delivery Rev"},{"key":"3927_CR59","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1158\/0008-5472.CAN-11-2449","volume":"71","author":"N Obermajer","year":"2011","unstructured":"Obermajer N, Muthuswamy R, Odunsi K, et al. PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res. 2011;71:7463\u201370.","journal-title":"Cancer Res"},{"key":"3927_CR60","doi-asserted-by":"publisher","first-page":"e2636","DOI":"10.1097\/MD.0000000000002636","volume":"95","author":"J Zhang","year":"2016","unstructured":"Zhang J, Yan Y, Yang Y, et al. High infiltration of tumor-associated macrophages influences poor prognosis in human gastric cancer patients, associates with the phenomenon of EMT. Med (Baltim). 2016;95:e2636.","journal-title":"Med (Baltim)"},{"key":"3927_CR61","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.15252\/embj.201797345","volume":"36","author":"M Cort\u00e9s","year":"2017","unstructured":"Cort\u00e9s M, Sanchez-Moral L, de Barrios O, et al. Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles. EMBO J. 2017;36:3336\u201355.","journal-title":"EMBO J"},{"key":"3927_CR62","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West AP, Khoury-Hanold W, Staron M, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520:553\u20137.","journal-title":"Nature"},{"key":"3927_CR63","doi-asserted-by":"publisher","first-page":"2100065","DOI":"10.1002\/adtp.202100065","volume":"4","author":"M Gao","year":"2021","unstructured":"Gao M, Xie YQ, Lei K, et al. A manganese phosphate nanocluster activates the cGAS-STING pathway for enhanced cancer immunotherapy. Adv Ther. 2021;4:2100065.","journal-title":"Adv Ther"},{"key":"3927_CR64","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41419-022-04730-y","volume":"13","author":"M Tang","year":"2022","unstructured":"Tang M, Dong X, Xiao L, et al. CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma. Cell Death Dis. 2022;13:331.","journal-title":"Cell Death Dis"},{"key":"3927_CR65","doi-asserted-by":"publisher","first-page":"e0303138","DOI":"10.1371\/journal.pone.0303138","volume":"19","author":"X Song","year":"2024","unstructured":"Song X, Qu Z. NF-\u03baB1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-tax Transgenic mice. PLoS ONE. 2024;19:e0303138.","journal-title":"PLoS ONE"},{"key":"3927_CR66","doi-asserted-by":"publisher","first-page":"e0157288","DOI":"10.1371\/journal.pone.0157288","volume":"11","author":"AA Pozdzik","year":"2016","unstructured":"Pozdzik AA, Giordano L, Li G, et al. Blocking TGF-\u03b2 signaling pathway preserves mitochondrial proteostasis and reduces early activation of PDGFR\u03b2\u2009+\u2009pericytes in aristolochic acid induced acute kidney injury in Wistar male rats. PLoS ONE. 2016;11:e0157288.","journal-title":"PLoS ONE"},{"key":"3927_CR67","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13046-025-03285-y","volume":"44","author":"X Pan","year":"2025","unstructured":"Pan X, Wang W, Wang Y, et al. M2 macrophage-secreted KYNU promotes stemness remodeling and malignant behavior in endometrial cancer via the SOD2-mtROS-ERO1\u03b1-UPRER axis. J Exp Clin Cancer Res. 2025;44:193.","journal-title":"J Exp Clin Cancer Res"},{"key":"3927_CR68","doi-asserted-by":"publisher","first-page":"e1016697","DOI":"10.1080\/2162402X.2015.1016697","volume":"4","author":"S Domingos-Pereira","year":"2015","unstructured":"Domingos-Pereira S, Hojeij R, Reggi E, et al. Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor. Oncoimmunology. 2015;4:e1016697.","journal-title":"Oncoimmunology"},{"key":"3927_CR69","doi-asserted-by":"publisher","first-page":"eaam9169","DOI":"10.1126\/sciimmunol.aam9169","volume":"2","author":"JK Krishnaswamy","year":"2017","unstructured":"Krishnaswamy JK, Gowthaman U, Zhang B, et al. Migratory CD11b\u2009+\u2009conventional dendritic cells induce T follicular helper cell\u2013dependent antibody responses. Sci Immunol. 2017;2:eaam9169.","journal-title":"Sci Immunol"},{"key":"3927_CR70","doi-asserted-by":"publisher","first-page":"e010787","DOI":"10.1136\/jitc-2024-010787","volume":"13","author":"P Zhang","year":"2025","unstructured":"Zhang P, Wang D, Zhou G, et al. Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma. J ImmunoTher Cancer. 2025;13:e010787.","journal-title":"J ImmunoTher Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03927-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03927-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03927-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T23:05:54Z","timestamp":1763507154000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03927-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3927"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03927-9","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was based on publicly available transcriptomic and clinical data from the TCGA-BLCA and GEO-GSE13507, GSE32894 datasets. As per the guidelines for using public datasets, formal ethical approval from an institutional review board and individual patient consent were not required for this study. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2123"}}